Hematologic Malignancy

Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

CI-CAN-00003740CTCL · PCTCLExplore in graph →

Hematologic59 active trials10 approved drugs

NCIt: C3467
MeSH: D016410

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 30
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (73)

No study matches these filters